Source:http://linkedlifedata.com/resource/pubmed/id/11600185
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2001-10-15
|
| pubmed:abstractText |
The glial cell line-derived neurotrophic factor (GDNF) is an important neurotrophic and potential differentiation factor for dopaminergic systems. Both the dopamine theory and the neurodevelopmental hypothesis of schizophrenia suggest that alterations of GDNF functions could be involved in the pathogenesis of schizophrenia. Using polymerase chain reaction and single strand conformational polymorphism analysis, we searched for polymorphisms in the GDNF gene in 50 patients with schizophrenia. No evidence was obtained, however, for the presence of polymorphisms in the DNA sequence encoding GDNF mature peptide in our patients. We then examined a trinucleotide repeat (AGG)(n) polymorphism in the 3'-UTR of the GDNF gene for allelic association in a Japanese sample of 99 schizophrenic patients and 98 control subjects. There was no significant difference in the overall distribution of the allele between the two groups. When each allele was examined separately, the allele (AGG)(10) was more common in schizophrenic patients than in control subjects, but this finding was not significant when multiple testing was taken into account in the analysis. Overall, we obtained no solid evidence for the involvement of the GDNF gene in the pathogenesis of schizophrenia, although further studies in larger numbers of subjects will be required to conclude whether the trinucleotide repeat polymorphism is associated with the development of schizophrenia.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0165-1781
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
10
|
| pubmed:volume |
104
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
11-7
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:11600185-Adult,
pubmed-meshheading:11600185-Alleles,
pubmed-meshheading:11600185-Female,
pubmed-meshheading:11600185-Genetic Predisposition to Disease,
pubmed-meshheading:11600185-Genetic Testing,
pubmed-meshheading:11600185-Glial Cell Line-Derived Neurotrophic Factor,
pubmed-meshheading:11600185-Humans,
pubmed-meshheading:11600185-Male,
pubmed-meshheading:11600185-Middle Aged,
pubmed-meshheading:11600185-Nerve Growth Factors,
pubmed-meshheading:11600185-Nerve Tissue Proteins,
pubmed-meshheading:11600185-Polymerase Chain Reaction,
pubmed-meshheading:11600185-Polymorphism, Genetic,
pubmed-meshheading:11600185-Polymorphism, Single-Stranded Conformational,
pubmed-meshheading:11600185-Predictive Value of Tests,
pubmed-meshheading:11600185-Risk Factors,
pubmed-meshheading:11600185-Schizophrenia,
pubmed-meshheading:11600185-Trinucleotide Repeats
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Glial cell line-derived neurotrophic factor (GDNF) gene and schizophrenia: polymorphism screening and association analysis.
|
| pubmed:affiliation |
Department of Psychiatry, Teikyo University School of Medicine, 11-1, Kaga 2 Chome, Itabashi-ku, Tokyo 173-8605, Japan.
|
| pubmed:publicationType |
Journal Article
|